Prognosis in Myelodysplastic Syndromes: The Clinical Challenge of Genomic Integration

Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic neoplasms characterized by ineffective hematopoiesis and myelodysplasia with a variable spectrum of clinical–biological features that can be used to build a prognostic estimation. This review summarizes the current most widely used...

Descripción completa

Detalles Bibliográficos
Autor principal: Chen-Liang, Tzu-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151135/
https://www.ncbi.nlm.nih.gov/pubmed/34064707
http://dx.doi.org/10.3390/jcm10102052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151135/
https://www.ncbi.nlm.nih.gov/pubmed/34064707
http://dx.doi.org/10.3390/jcm10102052

Ejemplares similares